JP2013507945A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507945A5
JP2013507945A5 JP2012534715A JP2012534715A JP2013507945A5 JP 2013507945 A5 JP2013507945 A5 JP 2013507945A5 JP 2012534715 A JP2012534715 A JP 2012534715A JP 2012534715 A JP2012534715 A JP 2012534715A JP 2013507945 A5 JP2013507945 A5 JP 2013507945A5
Authority
JP
Japan
Prior art keywords
cells
peripheral blood
regulatory
contacting
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012534715A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507945A (ja
Filing date
Publication date
Priority claimed from GBGB0918615.6A external-priority patent/GB0918615D0/en
Application filed filed Critical
Publication of JP2013507945A publication Critical patent/JP2013507945A/ja
Publication of JP2013507945A5 publication Critical patent/JP2013507945A5/ja
Pending legal-status Critical Current

Links

JP2012534715A 2009-10-23 2010-10-22 免疫調節活性を有する細胞集団、その製造方法及び使用 Pending JP2013507945A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0918615.6A GB0918615D0 (en) 2009-10-23 2009-10-23 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
GB0918615.6 2009-10-23
PCT/EP2010/066007 WO2011048222A1 (en) 2009-10-23 2010-10-22 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof

Publications (2)

Publication Number Publication Date
JP2013507945A JP2013507945A (ja) 2013-03-07
JP2013507945A5 true JP2013507945A5 (enExample) 2013-12-12

Family

ID=41426608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534715A Pending JP2013507945A (ja) 2009-10-23 2010-10-22 免疫調節活性を有する細胞集団、その製造方法及び使用

Country Status (6)

Country Link
US (1) US9969976B2 (enExample)
EP (1) EP2491115B1 (enExample)
JP (1) JP2013507945A (enExample)
ES (1) ES2479543T3 (enExample)
GB (1) GB0918615D0 (enExample)
WO (1) WO2011048222A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012156522A1 (en) 2011-05-19 2012-11-22 Tigenix Sa Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
ES2434853B1 (es) * 2012-06-12 2014-09-30 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Marcador molecular de potencia terapéutica de células madre mesenquimales humanas y sus usos
CN108289937A (zh) * 2015-06-03 2018-07-17 爱兰细胞技术公司 用于产生和递送来自干细胞的有益因子的方法和装置
US11291689B2 (en) 2015-06-03 2022-04-05 Aelan Cell Technologies, Inc. Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells
CN111601606A (zh) 2017-11-29 2020-08-28 菲格内有限责任公司 用于活化的成纤维细胞与免疫细胞的相互作用及其用途
WO2021076674A1 (en) * 2019-10-15 2021-04-22 Figene, Llc Fibroblast-based immunotherapy of graves disease
CN111979186B (zh) * 2020-08-21 2022-04-08 遵义医科大学附属医院 一种快速高效体外扩增人间充质干细胞的方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
AU2005228442A1 (en) * 2004-03-29 2005-10-13 Cytomatrix, Llc Methods for production of regulatory T cells and uses thereof
JP2006280307A (ja) * 2005-04-01 2006-10-19 Kyoto Univ 制御性t細胞の製造方法
JP5925408B2 (ja) 2005-09-23 2016-05-25 タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルTigenix S.A.U. 免疫調節活性を有する細胞集団、単離方法および使用
US8241621B2 (en) * 2006-12-18 2012-08-14 Medistem Laboratories Stem cell mediated treg activation/expansion for therapeutic immune modulation
GB0820397D0 (en) * 2008-11-07 2008-12-17 Cellerix Sa Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases

Similar Documents

Publication Publication Date Title
Ozaki Tan et al. Novel applications of mesenchymal stem cell-derived exosomes for myocardial infarction therapeutics
Neshat et al. Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions
JP2013507945A5 (enExample)
Ben Khelil et al. Harnessing antitumor CD4+ T cells for cancer immunotherapy
Terraza-Aguirre et al. Mechanisms behind the immunoregulatory dialogue between mesenchymal stem cells and Th17 cells
JP2015131795A5 (enExample)
Orsini et al. Defective generation and maturation of dendritic cells from monocytes in colorectal cancer patients during the course of disease
JP2013504542A5 (enExample)
MX2013004817A (es) Enfermedad inflamatoria.
JP2015057427A5 (enExample)
JP2016510727A5 (enExample)
AU2012274478A8 (en) Method for amplifying NK cells
JP5118624B2 (ja) 新規なヒトt細胞集団
JP2013027385A5 (enExample)
JP2014513722A5 (enExample)
JP2014515258A5 (enExample)
Chen et al. Mesenchymal-stem-cell-based strategies for retinal diseases
WO2013111969A1 (ko) 탄시논을 유효성분으로 함유하는 자연살해세포 분화 또는 활성 증진용 조성물
Nguyen et al. Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies
JP2013523886A5 (enExample)
RU2016146567A (ru) Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты
MX2007006355A (es) Epitopes antigenos de interleucina-21, anticuerpos relacionados y su uso en el campo medico.
JP2012519681A5 (enExample)
HRP20141230T1 (hr) Naäśini i postupci aktivne staniäśne imunoterapije raka upotrebom tumorskih stanica usmrä†enih visokim hidrostatskim tlakom, te dendritiäśkih stanica
KR101659158B1 (ko) 메트포민이 처리된 면역조절능을 갖는 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물